Overview


According to FutureWise analysis the Aneurysm Treatment Market in 2025 is 5.72 billion, and is expected to reach US$ 10.6 billion by 2033 at a CAGR of 8.02%. Growth in the industry is largely driven by the rising cases of cerebrovascular and peripheral aneurysms, advancements in minimally invasive techniques, and the availability of flow-diverting stents and endovascular coils. Furthermore, novel biologic therapies and image-guided robotics are set to enhance procedural accuracy and reduce postoperative complications.

An aneurysm is an outgrowth in the wall of an artery. It is formed when there's a weakened area in the artery. If not treated, it can burst open, causing internal bleeding, blood clots, and obstructing blood flow in the artery. A rupture or clot can be life-threatening depending upon the area where it is generated. Aneurysms do not show any cause of pain and often go unnoticed unless a break can be seen, which can be fatal and lead to a hazardous situation. Diagnosis typically involves imaging tests like CT scans, CT or MRI angiography, and ultrasound. Classifications of aneurysms are based on their size and formation, including fusiform, saccular, mycotic, and pseudoaneurysms. 

Management and treatment strategies aim to prevent aneurysm rupture. Depending on the aneurysm's type, location, and size, treatments may encompass medication to improve blood flow, control cholesterol, and lower blood pressure. Large aneurysms at risk of bursting may necessitate surgery, such as endovascular aneurysm repair (EVAR), open surgery, endovascular coiling (for cerebral aneurysms), microvascular clipping (for cerebral aneurysms), or catheter embolization. Early detection and appropriate treatment play crucial roles in managing aneurysms effectively.

Magnetically Guided Endothelial BioBots: Researchers have created biodegradable hydrogel carriers that contain magnetic nanoparticles and are coated with primed endothelial progenitor cells. These BioBots can be delivered through microcatheters and guided by external electromagnetic fields to adapt to the shapes of aneurysms. This approach promotes rapid endothelialization and reduces the risk of rupture.

FutureWise Market Research has published a report that provides an insightful analysis of Aneurysm Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Aneurysm Treatment Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Penumbra
  • Terumo Medical Incorporated
  • Medtronic Plc
  • Phenox GmbH B. Braun Melsungen AG
  • Stryker
  • Raumedic AG
  • DePuy Synthes
  • Integra Life Sciences Corporation
  • Orsan Medical Technologies
  • Spiegelberg GmbH
  • MicroPort Scientific Corporation
  • Codman
  • Shurtleff, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Aneurysm Treatment Market:

Penumbra

In February 2025, Penumbra introduced the ACCESS25™ delivery microcatheter, a single-lumen device designed to enhance access to the neurovasculature for delivering Penumbra’s 0.020-inch coil platform. Compatible with Midway intermediate and Benchmark/BMX guide catheters, this device aims to improve trackability and stability during neurovascular embolization procedures.

Terumo

In September 2025, Terumo Neuro launched the Aneurysm Treatment Alliance in the Europe, Middle East, and Africa (EMEA) region. This initiative aims to enhance physician collaboration and improve aneurysm care by granting access to Terumo's comprehensive portfolio of neurovascular products. The alliance focuses on advancing patient outcomes through innovative treatments and educational programs for healthcare professionals.

By Product Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow diverters

By End User

  • Hospitals
  • Neurological Centres

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Here’s a regional view of where the most progress is happening:

North America is at the forefront of the Aneurysm Treatment Market, primarily due to several factors:

  • Advanced healthcare infrastructure and early adoption of innovative technologies.
  • A skilled workforce of healthcare professionals specializing in minimally invasive and endovascular procedures.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Aneurysm Treatment Market By Product Type, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Aneurysm Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Aneurysm Treatment Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aneurysm Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Aneurysm Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Aneurysm Treatment Market, By Product Type Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Surgical Clipping
        2. Endovascular Coiling
        3. Flow diverters

  • 8.   Global Aneurysm Treatment Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Neurological Centres

  • 9.   North America Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 10.   Latin America Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 11.   Europe Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 12.   Asia Pacific Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 13.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 14.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Penumbra
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Terumo Medical Incorporated
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Phenox GmbH B. Braun Melsungen AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Stryker
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Raumedic AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. DePuy Synthes
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Integra Life Sciences Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Orsan Medical Technologies
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Spiegelberg GmbH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. MicroPort Scientific Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Codman
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Shurtleff, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client
    •   

FAQ


An aneurysm occurs when a blood vessel bulges due to a weakened wall. Treatment options include surgical repair, endovascular procedures, and minimally invasive techniques such as coiling, stenting, and flow diverters.

Endovascular Aneurysm Repair (EVAR), flow diverters and intrasaccular devices, surgical clipping, hybrid thoracic aortic repair devices, and minimally invasive catheter-based treatments.

Increasing global prevalence of aneurysms.

Greater adoption of minimally invasive and endovascular treatments.

Innovations in medical device technology.

Growth of healthcare infrastructure and investments in emerging regions.

Development of innovative coils, flow diverters, and biodegradable implants; expansion of hybrid surgical and endovascular procedures; integration of robotics and AI for precise aneurysm management; and an increase in clinical trials and real-world evidence studies to optimize patient outcomes.

Related Market

Aneurysm Coiling and Embolization Devices Market

Read More

Aortic Aneurysm Repair Market

Read More

Aortic Aneurysm Market

Read More

Flow Diversion Aneurysm Market

Read More
Partner

Our Clients